Amazon Expands Healthcare Strategy With GLP-1 Program… Rivals Brace For A Margin Squeeze
Amazon is going all in on the weight-loss drug boom… and competitors are not happy about it.
On Tuesday, Amazon said it’s launching a new GLP-1 program through Amazon One Medical, with the goal of making it easier for patients to actually get (and stay on) these increasingly popular treatments.
Instead of bouncing between a doctor’s office, a pharmacy, and your insurance company… Amazon is trying to wrap everything into one place. You can see a provider (virtually or in person), get a prescription, and have it filled through Amazon Pharmacy… all within the same system.
The program includes access to well-known GLP-1 drugs like Wegovy and Zepbound, along with newer oral options that are starting to hit the market.
On pricing, Amazon says patients with insurance could pay as little as $25 a month. For people paying out of pocket, oral medications start around $149 monthly, while injectable treatments begin closer to $299. That’s not dramatically cheaper than what’s already out there… but it’s competitive enough to scare competition.
Rather than competing aggressively on price, Amazon’s edge is convenience.
The program includes same-day delivery, quick prescription renewals, and accessible consultations, starting at $29 for messaging and $49 for video care. The goal is to take away the friction so people actually stay on the meds instead of dropping off halfway through, which tends to happen often.
Competitors immediately picked up on what that could mean.
Shares of Hims & Hers Health, Viking Therapeutics, Amgen, and Septerna all moved lower after the announcement, as the market started factoring in another deep-pocketed competitor entering the space.
That said, Amazon isn’t changing the science here. Demand for GLP-1 drugs has already exploded as studies show meaningful weight loss for patients over time.
What Amazon is trying to change is the experience around getting those drugs.
Instead of treating weight loss like a one-time prescription, the company is framing it as ongoing care… something managed continuously, with easier access and fewer steps along the way.
At the same time, Amazon said it plans to expand same-day medication delivery to 4,500 cities by the end of 2026, underscoring just how large it believes this opportunity could become.
At the time of publishing this article, Stocks.News holds positions in Amazon as mentioned in the article.